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Abstract
Purpose: Calcium supplements, typically calcium carbonate based, are prescribed for postmenopausal women as
an aid to prevent osteoporotic fractures. Recent literature suggests these calcium carbonate based supplements in
addition to having a low bioavailability, can have adverse side effects including increased risk of heart attack.
This study used a calcium–rich, marine multi-mineral complex (Aquamin) in an ovariectomised rat model of
osteoporosis to demonstrate its efficacy in comparison to calcium carbonate.
Methods: Animals were randomly assigned to either non-ovariectomy control (Control), ovariectomy plus
calcium carbonate (OVX), ovariectomy plus Aqaumin (Aquamin) or ovariectomy plus Aquamin delay where
treatment started at week 8 (Aquamin delay). At the end of the twenty week study, the trabecular architecture
was measured using micro computed tomography, composition was assessed using Fourier transform infrared
spectroscopy and the mechanical properties were determined using nanoindentation and three point bend testing.
Results: The study demonstrates that oral ingestion of Aquamin has the ability to preserve trabecular bone
structure, mineral composition, tissue level biomechanical properties and whole bone strength in the proximal
tibia of rats following ovariectomy better than calcium carbonate.
Conclusion: This study supports the use of Aquamin as a supplement to aid in the prevention of bone loss in
post-menopausal women.

Mini-Abstract
Calcium carbonate supplements are prescribed to prevent osteoporotic fractures. However, they are linked to
increased risk of heart attack. We examined a marine source of calcium, Aquamin, and determined that it
preserved bone structure better than calcium carbonate. Aquamin could be used in the prevention of bone loss in
post-menopausal women.
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Introduction
Osteoporosis is a disease that degrades bone mass and architecture, and impairs the ability of the skeleton to
perform fundamental mechanical functions. Physiologically, osteoporosis occurs due to an imbalance in bone
cell activity by which excessive resorption occurs without adequate new bone formation, thereby reducing total
bone mass. As a consequence, bone strength is reduced and typically fractures of the vertebrae, hip or
wrist occur potentially leading to deformity, severe pain and in some cases death. Osteoporosis causes more
than 8.9 million fractures annually worldwide, or one every three seconds, approximately half of which occur in
Europe, corresponding with one fracture every 8 seconds [1]. These 4 million osteoporotic fractures are
estimated to cost the EU in the region of €31.7 billion, a figure which is expected to increase to €76.7 billion in
2050 based on the anticipated changes in the demography of Europe [2].
Calcium is a main constituent of the hydroxyapatite mineral which provides mechanical strength to the skeleton.
In addition to the skeletons’ roles of providing support, protection and enabling movement, it also acts as a
calcium reserve for the body. Therefore, when calcium levels elsewhere in the body are low, this triggers the
parathyroid hormone (PTH) to release calcium from bone by stimulating bone breakdown [3]. To prevent this
from occurring, many pre- and post-menopausal women are prescribed calcium supplements in a bid to avert
bone loss and prevent a fracture from occurring [4,5]. The majority of these calcium supplements are calcium
carbonate based, and have been linked to myocardial infarction, angina, transient ischaemic attack or stroke
[6,7]. A study published in the British Medical Journal stated that a reassessment of the role of calcium
supplements in the management of osteoporosis was warranted [8].
Aquamin is a natural, calcium-rich marine multi-mineral complex food supplement which is derived from the
calcified skeletal remains of the red marine algae species Lithothamnion, found off the coast of Ireland and
Iceland. It is available commercially in a number of forms, which have calcium concentrations ranging up to 31
weight percent (wt %). In addition to calcium, Aquamin also contains 73 other trace minerals including
magnesium, strontium, manganese, selenium, copper and zinc, which have been identified as important in bone
health [9]. Minerals from sea-water accumulate in the fronds of the algae during their lifetime, until eventually
the fronds break off and the calcified remains are harvested and processed. The supplement does not contain any
additives; the mineralised fronds are simply sterilised, dried and milled to produce the Aquamin supplements.
Unlike calcium carbonate, which is extracted from limestone or rock and is made up entirely of calcite,
Aquamin is crafted naturally in the sea, providing a unique porous honeycombed vegetative cell structure with
argonite, vaterite and calcite calcium salts present. This structure not only gives a number of significant benefits
in its chemical behaviour and its absorption, it also lowers serum lipid levels, a precursor to many
cardiovascular events, in postmenopausal women [10].
A number of recent trials have also identified several positive effects of Aquamin on bone health. Two doubleblind, placebo-controlled studies measured the bioavailability of Aquamin versus calcium carbonate. These
studies found that as early as 60 minutes following treatment, PTH levels were significantly reduced in the
Aquamin group compared to calcium carbonate and placebo groups. In-vitro studies on osteoblast cells cultured
in the presence of Aquamin exhibited early osteogenic potential and produced more mineral than those cultured
in its absence [11-13]. An in-vivo study in which Aquamin was used as a dietary supplement in mice on a high-
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fat Western diet (HFWD) showed that bone structure and function were preserved [14]. Indeed, the bone
structure of these mice was superior to that of mice on the standard low-fat diet, thus asserting the osteogenic
effect of Aquamin on bone cells. In a study conducted in yearling horses, Aquamin’s influence on bone turnover
was measured and found to be increased, suggesting that old or damaged bone could be replaced or removed
which could, in turn, reduce incidents of clinical bone injury [15]. These results indicate that Aquamin has the
potential to act as a supplement to enhance bone formation.
Using an established model of osteoporotic bone loss, the purpose of this study was to determine whether
Aquamin has the potential to prevent bone loss and function. A secondary aim was to assess Aquamin’s ability
to restore bone following significant loss. Specifically bone structure, composition and mechanical properties
were assessed in ovarectomised rats and those treated with Aquamin.
Methods
Animals
Eighty-eight female, retired breeder Wistar rats, both ovariectomised and age matched controls, were obtained
from Harlan Laboratories (UK) and allowed to acclimatize for 5 days before the start of the experiment (Week
0). The rats were maintained with a cycle of 12 hours light and 12 hours darkness. The experiment was
approved by the Animal Ethics Committee of Trinity College Dublin, Ireland and performed under licence
issued by the Department of Health. All applicable institutional and national guidelines for the care and use of
animals were followed. Two diets were used in this study, a regular murine chow (RM1) and a specially
formulated RM1 supplemented with Aquamin (both from Special Diet Services, UK). For the supplemented
feed, calcium (in the form of calcium carbonate) was removed from RM1 and Aquamin (31 wt% calcium) was
added at a concentration such that calcium levels were equal in both feeds. The rats were divided into four
groups: (1) control (n=28; RM1), (2) OVX (n=24, RM1), (3) OVX plus Aquamin (n=24, supplemented RM1)
and (4) OVX plus Aquamin delay (n=12; RM1 for 8 weeks followed by supplemented RM1). Rats were
ovariectomized one week prior to week 0, during the acclimatisation period all animals were fed RM1. At week
0, Aquamin treatment was started in group 3 while group 4 treatment started at week 8. Animals were allowed
to eat and drink ad libitum and routinely weighed before being euthanized at weeks 0, 2, 8, 12 and 20.
Micro Computed Tomography (MicroCT) (Structure and composition)
Following sacrifice, the left tibia was removed for microCT scanning (µCT40, Scanco, Switzerland) at two
locations. The midpoint of the tibia was identified and 10% of the tibial length was scanned around this position.
From the diaphyseal scans, the hydroxyapatite (HA) content was determined. The metaphyseal trabecular region
of the proximal tibia immediately below the epiphyseal growth plate was selected and 100 adjacent slices were
scanned. From these scans, the trabecular bone was manually selected and bone structural parameters of bone
volume fraction (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp)
and the hydroxyapatite content were automatically determined using Scanco software. Microarchitecture was
analyzed at a resolution of 8µm, at 70kVp and 114µA and a threshold value of 210.
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Fourier Transform Infrared Spectroscopy (FTIR) (Composition)
One-hundred micron thick samples were sectioned from the distal tibia using a diamond saw (Minitom, Struers,
Denmark). As water has a strong absorbance in the infrared, tissues are dehydrated before analyses, thus the
water spectrum is not observed. The dehydrated samples were placed on a calcium fluoride slide and positioned
on the microscope stage of the Spotlight 400 FTIR Imaging system (Perkin Elmer). The system is equipped with
an AutoImage microscope system operating with a 40X Cassegrain objective. A visible white-light image was
recorded of the sample and the area to be scanned using infra-red was specified. FTIR images were acquired in
attenuated total reflectance (ATR) imaging mode. The data were collected over the nominal free-scanning
spectral range, 4000 – 600 cm-1. Spectral measurements were acquired with a pixel size of 6.25 μm x 6.25 μm at
a

spectral

resolution

of
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cm-1. Background

measurements

were

acquired

on

a

region

with

no tissue with 120 scans per pixel, whereas 32 scans per pixel were recorded from the sample.
Nanoindentation Material Test (Mechanical properties)
Two-hundred micron thick samples were sectioned from the distal tibia (adjacent to the FTIR samples) using a
diamond saw (Minitom, Struers, Denmark) before being polished with a series of graded silica-carbide grinding
sheets. A Nano indenter XP system (MTS System Corporation, Oak Ridge, TN) was used to measure tissue
level mechanical properties of proximal tibia sections. The Young’s modulus (E) and contact hardness (H c) were
assessed using an AccuTip™ diamond Berkovich indenter tip with defined elastic modulus of 1141GPa, a
Poisson’s ratio equal to 0.07 and a radius of <50 nm. A total of twenty indents were performed on each sample:
10 evenly spaced indents in the cortical shell and a further 10 indents in the trabecular bone, five in an outer ring
and five in an inner ring at the centre of the sample. A permanent hardness impression was made by driving the
indenter into the sample for 90 s to a maximum load of 20 mN, holding for 120 s and then unloading. This cycle
was repeated 3 times at each location and the modulus was determined from the unloading segment of the final
indent [16].
Three-Point Bend Test (Mechanical properties)
Following microCT, a standard three-point bending test was applied to the tibia. The tibiae were placed on the
lateral surface on two rounded supporting bars with a distance of 12 mm between them. A preload of 1 N was
applied (Z020; Zwick, Ulm, Germany) at the medial surface of the diaphysis by lowering a third rounded bar. A
constant displacement rate of 5 mm/minute was applied until failure. Displacement was measured from the
actuator displacement transducer of the testing machine. Maximum load, maximum displacement and stiffness
were calculated for each sample.
Statistics
All results are presented in graphs as the mean ± standard deviation. For statistical analyses, results were tested
for normality with the Shapiro-Wilk test and outliers were identified using P-P plots and scatter plots. The
analysis was carried out using the SPSS software package (SPSS Inc., Chicago, IL). One-way ANOVA and the
Mann-Whitney rank sum tests were used to determine statistical significance. A difference of p ≤ 0.05 was
considered significant.
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Results
Structure
Three-dimensional and two-dimensional representative samples from each of the groups are shown in Figure 1.
These slices and reconstructions show an intact and well-connected trabecular microstructure in the control
samples. A significant loss of trabecular bone structure following 20 weeks of ovariectomy is evident in the
centre of the OVX samples. The trabecular structure is preserved when Aquamin administration is begun at
week 0. The Aquamin delay group has a structure which appears intermediate between the OVX and OVX+
Aquamin group.
Qualitative analysis shows that as early as week 2, the ovariectomized group displayed large changes in
structural parameters indicating the development of osteopenia (Figure 2). Significant losses in bone volume
fraction (BV/TV) were observed in the OVX group at week 8 following a strong trend at week 2 (p = 0.07).
Similarly trabecular separation (Tb.Sp) was significantly increased in the OVX group by week 12 while
trabecular number (Tb.N) was significantly reduced in the OVX group by week 20. No significant changes were
measured in trabecular thickness (Tr.Th) between groups over the study period.
Treatment with Aquamin resulted in a significant preservation of bone volume fraction by week 20 relative to
the OVX group. Although not significant, strong trends were evident by week 20 between OVX and the
Aquamin treated group with respect to Tr.N (p = 0.1) and Tr.Sp (p = 0.1). The Aquamin delay treatment group
showed strong trends although no significant improvement in trabecular architecture was measured following 8
weeks of normal chow and a subsequent 12 week Aquamin treatment.
Composition: Hydroxyapatite content
Hydroxyapatite content measured using microCT indicated a significant reduction in the HA content of both
trabecular and cortical bone by week 20 as seen in Figure 3. Beginning oral administration of Aquamin at week
0 prevented this loss in both trabecular and cortical bone. Beginning administration of Aquamin 8 weeks
following ovariectomy was also sufficient to prevent a significant loss of mineral content from trabecular bone.
Qualitative FTIR
In Figure 4a, the week 20 representative control sample visualised with white light (centre panel) shows bone
with a healthy micro architecture and good trabecular interconnectivity. The ATR spectrum which is recorded
can be represented as an absorbance spectrum. The same region of bone visualised as an absorbance heat map
(left hand panel) displays an abundance of red/orange indicating increased absorption on the surface of the
sample. In ATR mode (right hand panel), blue/purple indicates increased reflection at the surface. Visual
inspection of the white light and infrared maps for the OVX sample shows significant microarchitecture
deterioration and less absorption and reflection than in the control group. Treatment with Aquamin shows
increased absorbance represented by the increased presence of red in absorbance and purple/blue in the ATR
heat maps. The Aquamin delay group displays absorbance and reflection profiles which are intermediate to the
OVX and the Aquamin groups as indicated by red and green in the absorbance and purple and green in the ATR
maps.
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Quantitative FTIR
The infrared spectrum of bone shows the presence of the major molecular species, phosphate (from the mineral
hydroxyapatite), carbonate (from carbonate substitution for hydroxyl and phosphate groups), and amide I, II,
and III from the protein constituents of bone (mainly type I collagen) [17]. These peaks are shown in a
representative spectrum from a healthy control sample in Figure 4b. The mineral/matrix ratio is linearly related
to the mineral content and the carbonate/phosphate ratio is related to the chemically measured
carbonate/phosphate content. In the trabecular region from each absorbance spectrum, the mineral-to-matrix
ratio was assessed as the ratio of the area of the phosphate band (1170 - 980 cm-1) to the area of the amide I
band (1712 - 1592 cm-1). The carbonate/phosphate ratio was assessed as the ratio of the area of the phosphate
band to the area of the carbonate band (890-840 cm-1) [17]. Analysis of the ATR spectra (Figure 4c) indicates a
significant reduction in the mineral/matrix ratio in the OVX group relative to the control group at week 20. This
reduction of mineral/matrix ratio was prevented by starting Aquamin administration at week 0. The late
administration of Aquamin did not significantly prevent the change in mineral/matrix ratio. No significant
changes were measured in the carbonate/phosphate ratio between groups (Figure 4d).
Biomechanical Properties
Nanoindentation Material Test
The Young’s modulus and hardness data are presented in Table 1. In the control group, the value of the Young’s
modulus is lowest in the cortical shell, increasing significantly in trabeculae near the edge of this cortical shell
and increasing again in trabeculae at the core of the sample. A similar pattern is seen for the hardness. In the
OVX group, this stepwise increase disappears and there is only a significant difference between the core
trabeculae and the edge/cortical shell when the modulus is assessed and there are no differences between
locations when hardness is analysed. In the OVX + Aquamin group, trabecular bone moduli and hardness values
are significantly greater than the cortical shell values. No significant differences were measured in the OVX +
Aquamin delay group.
Analysis between groups in trabecular bone from the core found the modulus for the control group to be
significantly higher than the OVX and the OVX + Aquamin delay groups. The OVX + Aquamin group was not
significantly different from the control group although it was trending higher than the OVX group. Similar
results were observed for hardness. For trabeculae located around the edge of the sample, both the modulus and
hardness in the OVX + Aquamin group was significantly greater than that for the OVX group. For cortical bone,
both moduli and hardness in the OVX + Aquamin delay group were significantly higher than measured in the
control group. Hardness in cortical bone from the OVX + Aquamin group was also higher than the control
group.
Three-Point Bend Test
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Analysis of the cortical shell by three point bend test found a significant reduction in the maximum load
sustained by the OVX group between week 2 and week 20 (Table 4). No significant differences were measured
in maximum displacement between any of the groups or over the study duration. A significant increase in
stiffness was measured in the OVX + Aquamin group compared to OVX at week 20.

Discussion
In this study we examined the effects of ovariectomy and a natural, calcium-rich marine multi-mineral complex
on bone structure, composition and strength in a rat model of osteoporosis. The results of the study indicate that
Aquamin has the potential to prevent the loss of trabecular bone in the proximal tibia of ovariectomised rats
following 20 weeks of treatment. This protection of structure was accompanied by a preservation of the mineral
composition and follows through to maintaining the mechanical integrity. Analysis of the samples from animals
subject to the delayed Aquamin treatment was inconclusive for a number of reasons which are discussed in
further detail in this discussion. The use of a non-ovariectomy control fed group proved the efficacy of our
model as significant losses in bone volume were observed and measured in the ovariectomy group as early as 8
weeks when compared to the non-ovariectomy control. This loss of structure was accompanied by a degradation
in the composition and mechanical properties of the remaining bone, typical characteristics of osteoporosis.
In the current study, both the regular chow (RM1) and the Aquamin supplemented chow have equal amounts of
calcium. Therefore, the Aquamin treated animals did not receive extra dietary calcium. The significant
inhibition of bone loss, measured by week 20 in this study, is therefore not a result of the quantity of calcium
ingested. The significant preservation of the trabecular structure in the Aquamin groups is most likely brought
about by the unique form in which the calcium is supplied by Aquamin. Since calcium’s role in the prevention
of osteoporosis in humans was proven some 30 years ago, its bioavailability has been the subject of numerous
scientific studies. Calcium carbonate is typically used as the calcium supplement of choice worldwide, however,
it is known that its bioavailability is very low, only around 20–30% [18]. The form of dietary calcium is a
critical factor in determining the availability of calcium for bone development and maintenance. The structure of
the calcium salts in Aquamin dramatically increase the calcium surface area, thus stomach acid can come into
greater contact with the calcium making it easy to dissolve into the body and providing greater efficacy.
Additionally, calcium carbonate is not easily absorbed as the phosphorus binds tightly to the calcium.
This difference in bioavailability is one of the factors postulated to explain the positive Aquamin results
observed in this study. In addition to calcium, Aquamin also contains 73 additional minerals many of which
have a proven osteogenic potential through direct or indirect effects on bone cells or bone mineral and collagen.
Magnesium is a major component of Aquamin, it is essential for all living cells, including osteoblasts and
osteoclasts, as it is fundamental in adenosine triphosphate [19]. However, its role in bone is not confined to
simply cell biology, a dietary magnesium restriction has been shown to promote osteoporosis [20]. Potassium is
critical for calcium metabolism in many enzymes and potassium is also required for improved bone strength and
density [21]. Copper plays a role in collagen crosslinking and fixing calcium within bones [22]. Some elements,
such as strontium, are chemically similar to calcium. Strontium has an anabolic activity in bone, and this may
have significant beneficial effects on bone balance in normal and osteopenic animals [23]. The osteogenic effect
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offered by these elements in combination with a readily available calcium source will likely have a synergistic
effect. It is also recognised that calcium bioavailability is influenced and enhanced by the presence of other
minerals [24]. Aquamin also contains a unique trace mineral proﬁle gained from its marine source. Alone, these
elements may be insigniﬁcant, but within a multi-mineral matrix they work synergistically and may give a
powerful boost to the action of the calcium.
Starting oral administration of Aquamin immediately following ovariectomy demonstrated the capacity to
prevent trabecular bone loss in the proximal tibia of rats associated with ovariectomy. Although only bone
volume fraction was significantly altered by Aquamin, it is important to note that trabecular number, separation
and thickness are all incorporated into the software calculation of the trabecular bone volume fraction.
Therefore, while individually these parameters were unchanged, collectively they resulted in the overall
reduction in bone loss which can be seen visually in the microCT 2-dimensional slices and the 3-dimensional
reconstructions. It is important to note that Aquamin is a neutraceutical and is not as potent as pharmaceuticals.
Therefore, to achieve a significant preservation of trabecular architecture after only 20 weeks by simply
substituting calcium carbonate for Aquamin is a major outcome.
Bone is a composite material consisting of a mineral phase (hydroxyapatite), collagen, non-collagenous
proteins, lipids, and water [25]. Fourier transform infrared spectroscopy can show the presence of the major
molecular species, phosphate (from the mineral hydroxyapatite), carbonate (from carbonate substitution for
hydroxyl and phosphate groups), and amide I, II, and III from the protein constituents of bone (mainly type I
collagen). In the current study there was a significant reduction in the mineral-matrix ratio measured in
trabecular bone from the ovariectomised group at week 20. This is consistent with previous findings which
found a significant reduction in the mineral-matrix ratio in normal vs. osteoporotic bone [17]. This data is
supported by the significant reduction in hydroxyapatite measured in both the trabecular and compact bone from
the ovariectomised animals. The FTIR mapping of the control samples was also indicative of a high mineral
content. In contrast the ovariectomy group showed reduced absorption indicating a reduced mineral level. Those
animals which started Aquamin treatment immediately after ovariectomy were found to have a mineral-matrix
ratio significantly greater than the ovariectomy only group indicating a preservation of the healthy composition.
Again this is borne out in the HA data from microCT analysis where HA content was higher in the Aquamin
treated group than OVX. FTIR maps of the Aquamin treated group were more akin to the control group
signifying the preservation of mineral. The carbonate-phosphate ratio indicates the level of carbonate
substitution in the HA crystal, a decrease in this ratio reflecting an increased phosphate content. However, no
significant difference was seen in the carbonate-phosphate ratio in the current study.
In tandem with the significant changes in composition measured using FTIR and microCT were changes in the
tissue level mechanical properties as measured using nanoindentation. The biomechanical parameters of
trabecular bone from slices adjacent to those used in FTIR revealed unsurprising parallels. The Young’s
modulus of trabecular bone from ovariectomised animals was significantly less than the controls. This correlates
with data from previous studies examining the tissue level mechanical properties of ovariectomised bone
compared to healthy samples [16,26]. Trabeculae from animals who received Aquamin had a significantly
higher modulus and hardness than from ovariectomised animals. While this effect has not been demonstrated
previously, it is in keeping with the preservation of composition by Aquamin shown in the study.
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The nanoindentation results did yield some interesting data in terms of the cortical bone. Material strength
assessment showed that both modulus and hardness in the Aquamin delay group were significantly greater than
the control group. Although not significant, both modulus and hardness were higher in the cortical shell of
ovariectomised animals and the Aquamin treated group than of controls. Supporting this was the hydroxyapatite
content which was not significantly different between the control and either Aquamin groups. Micro-CT data
indicated a sustained loss of trabecular bone volume following ovariectomy over the 20 week study. However,
when the trabecular thickness was examined it was found to decrease until week 8 at which point it began to
increase again. This data supports the theory of bone compensation whereby new bone is laid down on surviving
trabeculae to compensate for the loss of other trabeculae [27,28]. In addition to laying down new bone in
trabeculae, new bone may also be laid down in the cortical shell [29]. However, as many studies have shown a
thinning of the cortical shell this is probably not the case and the current study showed an overall reduction in
the maximum load sustained by the tibial shaft from ovariectomised animals between weeks 2 and 20. It is
possible that secondary mineralisation is increased in the cortical bone. In conjunction with the availability of
Aquamin this could account for the higher tissue level mechanical values measured. Mechanical testing of the
whole tibial shaft did go some way towards supporting this theory. The stiffness measured in the Aquamin
group was significantly greater than the OVX. Although not significant, a higher maximum load was measured
in the Aquamin (132 ± 13 N) and Aquamin delay (136 ± 12 N) than in the control (121 ± 10 N). It is not
immediately clear what influence Aquamin in combination with ovariectomy had on compact bone and further
investigation of this is warranted.
To help with those assessments, a longer term study would advance our understanding of how Aquamin
behaves. An extended duration would likely have yielded additional significant changes due to Aquamin and
also the response to a delayed Aquamin therapy. Further study is also required to fully ascertain the timeframes
involved for a delayed treatment regime to be effective. It would also be interesting to measure bone formation
and resorption rates in further studies. This could be conducted by either looking at serum biomarkers or
through the use of fluorochrome markers to determine where bone formation is taking place. Clinically, calcium
is prescribed in combination with vitamin D. Therefore an assessment of the combined influence of Aquamin
and vitamin D would be merited.
Conclusion
This study has demonstrated that providing calcium in the form of a seaweed derived mineral supplement,
namely Aquamin, offers significant advantages over calcium carbonate. Trabecular architecture is significantly
preserved when using Aquamin as compared to calcium carbonate. This is supported by a preservation of the
mineral phase of bone which is mirrored by the improved material properties of the bone. Overall, this study
supports the use of Aquamin as a supplement to aid in the prevention of bone loss in post-menopausal women.
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Table 1: The Young’s Modulus and hardness measured in the cortical shell and in trabecular bone
from the core and the edge of the proximal tibia at week 20.
Modulus (GPa)
Location

Control

OVX

7.61 ± 3.67

a

Edge

5.56 ± 3.87

b

Cortical Shell

3.35 ± 0.51

Core

5.44 ± 2.53

OVX + Aquamin

OVX + Aquamin
ab

3.71 ± 1.94
3.86 ± 2.55

*

5.13 ± 0.97 *

b#

3.91 ± 0.71

5.99 ± 1.20
5.48 ± 0.95

Delay

b

4.10 ± 0.55

4.70 ± 0.67 **

Hardness (GPa)
Location

Control

Core

0.43 ± 0.10

Edge
Cortical Shell

OVX
a

OVX + Aquamin

OVX + Aquamin

Delay

b

0.37 ± 0.07

0.42 ± 0.08

0.37 ± 0.08 b #

0.28 ± 0.06

0.38 ± 0.07 b # %

0.24 ± 0.04

0.25 ± 0.03

0.27 ± 0.04 ^

0.29 ± 0.05 * &
0.24 ± 0.04
0.27 ± 0.04 ^

Mean ± standard deviation. Significant difference of p ≤ 0.05 between locations: > edge, b > cortical
a

shell. Between groups: * < control, # > OVX, ** > control, & < OVX + Aquamin, % > OVX +
Aquamin delay, ^ > control.
Table 2: Maximum load, maximum displacement and stiffness measured using three point bend
testing of the tibia.
Mechanical
Property

Group

Week 0

Week 2

Week 20

Control

129.62 ± 2.02

128.03 ± 20.19

121.12 ± 10.20

OVX

-

141.80 ± 9.41

122.23 ± 12.10 *

OVX + Aquamin

-

132.26 ± 19.36

131.85 ± 13.96

-

-

136.80 ± 12.11

Control

0.55 ± 0.14

0.54 ± 0.09

0.55 ± 0.13

OVX

-

0.53 ± 0.15

0.54 ± 0.14

OVX + Aquamin

-

0.54 ± 0.24

0.51 ± 0.2

-

-

0.47 ± 0.06

Control

244.39 ± 59.76

247.86 ± 72.58

292.93 ± 66.37

OVX

-

297.35 ± 128.59

257.95 ± 67.10

OVX + Aquamin

-

296.39 ± 140.21

368.25 ± 86.11#

-

-

293.19 ± 51.24

Maximum
Load
(N)

OVX + Aquamin
Delay

Maximum
Displacement
(mm)

OVX + Aquamin
Delay

Stiffness
(N/mm)

OVX + Aquamin
Delay

Significant difference of p ≤ 0.05: Within the OVX group, * > week 2. Between groups, # > OVX.
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Fig 1: Representative (a) 3-dimensional microCT reconstructions of trabecular bone from the
proximal tibia and (b) 2-dimensional slices through the midsection of the proximal tibia of rats at
week 20.

Fig 2: Percentage change in structural parameters in the metaphyseal proximal tibia for all groups
over all time points. N = 6 per group (* indicates p < 0.05 and ** p <0.005 between control and OVX,
# indicates p < 0.05 between OVX and OVX + Aquamin).
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Fig 3: Hydroxyapatite content measured using microCT indicates a significant reduction in HA
content in both trabecular and cortical bone following twenty weeks of ovariectomy. Aquamin
administration prevented this loss of HA in both bone types and a significant preservation was also
seen in the Aquamin delay group (* indicates p<0.05 between control, # indicates p<0.05 between
OVX).

Fig 4: (a) FTIR absorbance (left) and reflection (right) heat maps with white light image (centre) from
a representative sample of each group at week 20. In the absorbance maps areas of red indicate
increased absorbance (mineralisation) while in infra-red reflection maps, purple indicates increased
mineralisation. (b) Typical absorbance spectrum of bone indicating peaks used to calculate
17

mineral/matrix ratio and carbonate/phosphate ratios. (c) The mineral/matrix ratio was significantly
reduced following 20 weeks of estrogen deficiency (* p<0.05 relative to control). This loss of mineral
was prevented by administering Aquamin from week 0 (# p<0.05 relative to OVX). (d) No significant
changes were measured in the carbonate/phosphate ratio between groups.
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